VASOPLAN

This brand name is authorized in Turkey

Active ingredients

The drug VASOPLAN contains one active pharmaceutical ingredient (API):

1 Pentoxifylline
UNII SD6QCT3TSU - PENTOXIFYLLINE

Pentoxifylline has been shown to increase leukocyte deformability and to inhibit neutrophil adhesion and activation.

Read about Pentoxifylline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C04AD03 Pentoxifylline C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AD Purine derivatives
Discover more medicines within C04AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699541030700, 8699541751315

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈